Sigilon Therapeutics SGTX
$ 22.47
0.0%
Quarterly report 2023-Q2
added 08-07-2023
Country |
USA |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Rogerio Vivaldi Coelho M.B.A. |
Employees in the company |
- |
Shares |
32.4 M |
Market Cap[1] |
$ 728 M |
EBITDA (LTM) |
$ -35.9 M |
P/E (LTM) |
-2.48 |
P/S (LTM) |
41.66 |
EPS (LTM) |
-9.26 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.